{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:10:42Z","timestamp":1784542242268,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Medical and Health Science and Technology Project of Zhejiang","award":["2021KY281"],"award-info":[{"award-number":["2021KY281"]}]},{"name":"Ningbo Natural Science Foundation Project","award":["202003N4274"],"award-info":[{"award-number":["202003N4274"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Accurate prediction of acute exacerbation helps select patients with chronic obstructive pulmonary disease (COPD) for individualized therapy. The potential of lymphocyte subsets to function as clinical predictive factors for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) remains uncertain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this single-center prospective cohort study with a 2-year follow-up, 137 patients aged 51 to 79 with AECOPD were enrolled. We examined the prognostic indicators of AECOPD by analyzing lymphocyte subsets and baseline symptom score. Furthermore, a predictive model was constructed to anticipate the occurrence of respiratory failure in patients experiencing AECOPD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The COPD Assessment Test (CAT) score combined with home oxygen therapy and CD4<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells% to predict respiratory failure in AECOPD patients were the best (the area under the curves [AUC]\u2009=\u20090.77, 95% CI: 0.70\u20130.86, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001, sensitivity: 60.4%, specificity: 86.8%). The nomogram model, the C index, calibration plot, decision curve analysis, and clinical impact curve all indicate the model\u2019s good predictive performance. The observed decrease in the proportions of CD4<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells appears to be correlated with more unfavorable outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The nomogram model, developed to forecast respiratory failure in patients with AECOPD, utilizing variables such as home oxygen therapy, CAT score, and CD4<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells%, demonstrated a high level of practicality in clinical settings. CD4<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells serve as a reliable and readily accessible predictor of AECOPD, exhibiting greater stability compared to other indices. It is less susceptible to subjective influences from patients or physicians. This model facilitated personalized estimations, enabling healthcare professionals to make informed decisions regarding preventive interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02751-7","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T05:02:08Z","timestamp":1701234128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The predictive value of baseline symptom score and the peripheral CD4CD8 double-positive T cells in patients with AECOPD"],"prefix":"10.1186","volume":"23","author":[{"given":"Shiyi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"issue":"2","key":"2751_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","volume":"106","author":"NR Anthonisen","year":"1987","unstructured":"Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196\u2013204.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2751_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/fampra\/cmt055","volume":"30","author":"S Al-ani","year":"2013","unstructured":"Al-ani S, Spigt M, Hofset P, Melbye H. Predictors of exacerbations of asthma and COPD during one year in primary care. Fam Pract. 2013;30(6):621\u20138.","journal-title":"Fam Pract"},{"issue":"12","key":"2751_CR3","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128\u201338.","journal-title":"N Engl J Med"},{"issue":"9589","key":"2751_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","volume":"370","author":"AS Buist","year":"2007","unstructured":"Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741\u201350.","journal-title":"Lancet"},{"issue":"1","key":"2751_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010020","volume":"1","author":"PJ Barnes","year":"2004","unstructured":"Barnes PJ, Cosio MG. Characterization of T lymphocytes in chronic obstructive pulmonary disease. PLoS Med. 2004;1(1): e20.","journal-title":"PLoS Med"},{"issue":"10","key":"2751_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","volume":"173","author":"A Papi","year":"2006","unstructured":"Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"2751_CR7","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1128\/IAI.73.12.8161-8166.2005","volume":"73","author":"TF Murphy","year":"2005","unstructured":"Murphy TF, Brauer AL, Aebi C, Sethi S. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun. 2005;73(12):8161\u20136.","journal-title":"Infect Immun"},{"issue":"2","key":"2751_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/IAI.72.2.818-823.2004","volume":"72","author":"D Bogaert","year":"2004","unstructured":"Bogaert D, van der Valk P, Ramdin R, Sluijter M, Monninkhof E, Hendrix R, de Groot R, Hermans PW. Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease. Infect Immun. 2004;72(2):818\u201323.","journal-title":"Infect Immun"},{"issue":"2","key":"2751_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14656566.2019.1701656","volume":"21","author":"TE Albertson","year":"2020","unstructured":"Albertson TE, Chenoweth JA, Pearson SJ, Murin S. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opin Pharmacother. 2020;21(2):213\u201331.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"2751_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00011-020-01408-z","volume":"70","author":"M Williams","year":"2021","unstructured":"Williams M, Todd I, Fairclough LC. The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review. Inflamm Res. 2021;70(1):11\u20138.","journal-title":"Inflamm Res"},{"key":"2751_CR11","doi-asserted-by":"crossref","unstructured":"He S, Wu S, Chen T, Cao C: Using complete blood count, serum immunoglobulins G\/A\/M and complement C3\/C4 levels to predict the risk of COPD acute exacerbation: 2-year follow-up in a single-center prospective cohort study. Clin Exp Med 2023.","DOI":"10.1007\/s10238-023-01117-x"},{"key":"2751_CR12","doi-asserted-by":"crossref","unstructured":"Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med 1991, 85 Suppl B:25\u201331; discussion 33\u201327.","DOI":"10.1016\/S0954-6111(06)80166-6"},{"issue":"2","key":"2751_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1590\/S1806-37132006000200006","volume":"32","author":"A Camelier","year":"2006","unstructured":"Camelier A, Rosa FW, Salim C, Nascimento OA, Cardoso F, Jardim JR. Using the Saint George\u2019s Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol. 2006;32(2):114\u201322.","journal-title":"J Bras Pneumol"},{"issue":"3","key":"2751_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648\u201354.","journal-title":"Eur Respir J"},{"issue":"3","key":"2751_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/096228029600500306","volume":"5","author":"LM LaVange","year":"1996","unstructured":"LaVange LM, Stearns SC, Lafata JE, Koch GG, Shah BV. Innovative strategies using SUDAAN for analysis of health surveys with complex samples. Stat Methods Med Res. 1996;5(3):311\u201329.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"2751_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1378\/chest.122.2.437","volume":"122","author":"WD Kim","year":"2002","unstructured":"Kim WD, Kim WS, Koh Y, Lee SD, Lim CM, Kim DS, Cho YJ. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest. 2002;122(2):437\u201344.","journal-title":"Chest"},{"key":"2751_CR17","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2023 Report. www.goldcopd.org (Accessed on20 January 2023)."},{"issue":"1","key":"2751_CR18","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1038\/s41598-021-84439-8","volume":"11","author":"T Karauda","year":"2021","unstructured":"Karauda T, Kornicki K, Jarri A, Antczak A, Mi\u0142kowska-Dymanowska J, Piotrowski WJ, Majewski S, G\u00f3rski P, Bia\u0142as AJ. Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD. Sci Rep. 2021;11(1):4804.","journal-title":"Sci Rep"},{"issue":"1","key":"2751_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12931-016-0456-y","volume":"17","author":"JX Geerdink","year":"2016","unstructured":"Geerdink JX, Simons SO, Pike R, Stauss HJ, Heijdra YF, Hurst JR. Differences in systemic adaptive immunity contribute to the \u201cfrequent exacerbator\u201d COPD phenotype. Respir Res. 2016;17(1):140.","journal-title":"Respir Res"},{"issue":"3","key":"2751_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.autrev.2003.09.001","volume":"3","author":"Y Parel","year":"2004","unstructured":"Parel Y, Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev. 2004;3(3):215\u201320.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2751_CR21","first-page":"241","volume":"2","author":"K Bahadori","year":"2007","unstructured":"Bahadori K, FitzGerald JM. Risk factors of hospitalization and readmission of patients with COPD exacerbation\u2013systematic review. Int J Chron Obstruct Pulmon Dis. 2007;2(3):241\u201351.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"2751_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.rmed.2013.12.014","volume":"108","author":"SD Lee","year":"2014","unstructured":"Lee SD, Huang MS, Kang J, Lin CH, Park MJ, Oh YM, Kwon N, Jones PW, Sajkov D. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014;108(4):600\u20138.","journal-title":"Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02751-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02751-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02751-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T05:02:19Z","timestamp":1701234139000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02751-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2751"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02751-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"16 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Commission of Ningbo First Hospital and written informed consent was obtained from each participant. All the methods included in this study are in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}